查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1436222

濫用藥物 (DOA) 測試 2024 年全球市場報告

Drugs of Abuse (DOA) Testing Global Market Report 2024
出版日期: 按訂單生產 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

濫用藥物 (DOA) 測試市場規模預計在未來幾年將顯著成長。預計到 2028 年將以 9.6% 的複合年成長率 (CAGR) 成長至 104.8 億美元。未來預測期內的預計成長與運動和競技測試的擴大、藥物測試意識和教育的提高、毒品相關犯罪的迅速增加、企業健康計劃的實施以及測試方法的進步有關。可能性。預計這段時期的主要趨勢包括可攜式和手持式檢測設備的使用、實驗室資訊管理系統（LIMS）的引入、合成藥物檢測的重點、大麻檢測需求的增加以及結果解釋的人工智慧。（AI）整合等

藥物濫用治療需求的成長預計將推動藥物濫用 (DOA) 檢測市場的成長。物質濫用或藥物濫用涉及個人對物質的有害使用。藥物測試在識別體內通常不存在的化合物方面發揮著重要作用。測試過程包括篩檢測試，以檢測和確認特定物質的存在。由於對藥物濫用治療的需求不斷增加，預計該市場將會擴大。例如，2021年6月，聯合國毒品犯罪防制署（UNODC）在其《世界毒品報告》中報告稱，全球有超過3,600萬人患有吸毒障礙。對藥物濫用治療的需求不斷成長是濫用藥物 (DOA) 檢測市場成長的關鍵驅動力。

醫院需求的不斷成長預計將推動濫用藥物（DOA）檢測市場的擴大。作為一個綜合醫療保健機構，醫院在為患病或受傷的個人提供廣泛的醫療服務、治療和護理方面發揮著重要作用。在醫院內整合濫用藥物 (DOA) 檢測有助於及早發現藥物濫用，實現客製化治療計劃，增強臨床決策，確保患者安全並提高公共安全。為衛生、職場安全和醫療資源的有效利用做出貢獻。截至 2023 年 8 月，英國共有 1,148 家醫院，凸顯了醫院在醫療保健服務中所扮演的重要角色。因此，醫院需求的增加是推動濫用藥物（DOA）檢測市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特點

第3章 市場趨勢與策略

第4章宏觀經濟情景

  • 高通膨對市場的影響
  • 烏克蘭與俄羅斯戰爭對市場的影響
  • COVID-19 對市場的影響

第5章世界市場規模與成長

  • 全球市場促進因素與限制因素
    • 市場促進因素
    • 市場限制因素
  • 2018-2023 年全球市場規模表現與成長
  • 全球市場規模預測與成長，2023-2028、2033

第6章市場區隔

  • 全球濫用藥物 (DOA) 測試市場，按產品和服務細分、績效和預測，2018-2023、2023-2028、2033
  • 分析儀
  • 快速檢測裝置
  • 消耗品
  • 檢驗服務
  • 全球濫用藥物 (DOA) 測試市場，按樣本類型細分、實際和預測，2018-2023、2023-2028、2033
  • 尿
  • 頭髮
  • 口腔液
  • 呼吸
  • 全球濫用藥物 (DOA) 測試市場，按應用、性能和預測細分，2018-2023、2023-2028、2033
  • 疼痛管理
  • 刑事司法
  • 職場篩檢
  • 全球濫用藥物 (DOA) 測試市場，按最終用戶細分、績效和預測，2018-2023、2023-2028、2033
  • 醫院
  • 診斷實驗室
  • 法醫學研究所
  • 其他最終用戶

第 7 章 區域與國家分析

  • 全球濫用藥物 (DOA) 測試市場、地區、績效和預測，2018-2023、2023-2028、2033
  • 全球濫用藥物 (DOA) 測試市場，按國家、實際和預測，2018-2023、2023-2028、2033

第8章亞太市場

第9章 中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章 義大利市場

第20章 西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章加拿大市場

第26章 南美洲市場

第27章 巴西市場

第28章 中東市場

第29章 非洲市場

第30章 競爭格局及公司概況

  • 濫用藥物（DOA）檢測市場的競爭格局
  • 濫用藥物 (DOA) 測試市場公司概況
    • Siemens AG
    • F. Hoffmann-La Roche Ltd.
    • Thermo Fisher Scientific Inc.
    • Abbott Laboratories
    • Danaher Corporation

第31章 其他大型創新公司

  • Laboratory Corporation of America Holdings
  • Quest Diagnostics Inc.
  • Zimmer Biomet Holdings Inc.
  • bioMerieux Inc.
  • Dragerwerk AG &Co. KGaA
  • Natera Inc.
  • Aegis Sciences Corporation
  • NMS Labs
  • Clinical Reference Laboratory Inc.
  • Cordant Health Solutions
  • Millennium Health
  • ACM Global Laboratories
  • Psychemedics Corporation
  • Alfa Scientific Designs Inc.
  • Alere Toxicology Services

第32章競爭基準化分析

第 33 章. 競爭對手儀表板

第34章 重大併購

第35章 未來前景與可能性分析

第36章附錄

簡介目錄
Product Code: r15548

Drug of abuse (DOA) testing involves examining substances, such as drugs, chemicals, or plant products, typically used recreationally. This includes marijuana, cocaine, opioids, amphetamines, alcohol, and PCP, which are screened for on a drug panel. Clinical screening methods use the patient's urine, saliva, blood, hair, or sweat for this purpose.

Drug of Abuse (DOA) testing encompasses various products and services, including analyzers, rapid testing devices, consumables, and laboratory services. Analyzers, automatic devices measuring chemical concentrations, play a crucial role in this domain. The testing involves sample types such as urine, hair, oral fluid, and breath, with applications in pain management, criminal justice, and workplace screening. End-users of DOA testing include hospitals, diagnostic laboratories, forensic laboratories, and other relevant entities.

The drugs of abuse (DOA) testing market research report is one of a series of new reports from. The Business Research Company that provides drugs of abuse (DOA) testing market statistics, including drugs of abuse (DOA) testing industry global market size, regional shares, competitors with a drugs of abuse (DOA) testing market share, detailed drugs of abuse (DOA) testing market segments, market trends and opportunities, and any further data you may need to thrive in the drugs of abuse (DOA) testing industry. This drug of abuse (DOA) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The drugs of abuse (doa) testing market size has grown strongly in recent years. It will grow from $6.6 billion in 2023 to $7.25 billion in 2024 at a compound annual growth rate (CAGR) of 9.8%. The growth witnessed in the historical period can be ascribed to factors such as government regulations and workplace policies, pre-employment screening practices, law enforcement and legal procedures, drug rehabilitation programs, and compliance measures within the transportation industry.

The drugs of abuse (doa) testing market size is expected to see strong growth in the next few years. It will grow to $10.48 billion in 2028 at a compound annual growth rate (CAGR) of 9.6%. The projected growth in the upcoming forecast period can be linked to the expansion of sports and athletics testing, heightened awareness and education regarding drug testing, a surge in drug-related crimes, the adoption of corporate wellness programs, and advancements in testing methods. Key trends anticipated in this period encompass the utilization of portable and handheld testing devices, the implementation of Laboratory Information Management Systems (LIMS), a focus on synthetic drug testing, a growing demand for cannabis testing, and the integration of artificial intelligence (AI) for result interpretation.

The rising demand for drug abuse treatment is anticipated to drive the growth of the drugs of abuse (DOA) testing market. Drug abuse, or substance abuse, involves the harmful use of substances by individuals. Drug testing plays a crucial role in identifying compounds not typically present in the body. The testing process includes screening tests followed by confirmatory tests to detect and verify the presence of specific substances. The growing need for drug abuse treatment is expected to contribute to the market's expansion. For example, in June 2021, the United Nations Office on Drugs and Crime (UNODC) reported in the World Drug Report that over 36 million individuals worldwide have drug use disorders. This increasing demand for drug abuse treatment is a key driver for the growth of the drugs of abuse (DOA) testing market.

The growing demand for hospitals is anticipated to drive the expansion of the drugs of abuse (DOA) testing market. Hospitals, as comprehensive healthcare institutions, play a crucial role in delivering a broad spectrum of medical services, treatment, and care for individuals facing illness or injury. The integration of drugs of abuse (DOA) testing within hospitals facilitates early detection of substance abuse, enabling customized treatment plans, enhancing clinical decision-making, ensuring patient safety, and contributing to public health, workplace safety, and efficient healthcare resource utilization. As of August 2023, there are reported to be 1148 hospitals in the UK, emphasizing the significant role hospitals play in healthcare services. Hence, the increasing demand for hospitals is a key factor propelling the growth of the drugs of abuse (DOA) testing market.

Major players in the drugs of abuse (DOA) testing market are directing their efforts towards developing cutting-edge products, including software-as-a-service (SaaS) platforms, to reinforce their market presence. Software-as-a-Service (SaaS) represents a software distribution model where applications are hosted by a third-party provider and accessed by customers over the internet. A notable example is the introduction of the Addison drug discovery software by Merck KGaA, a US-based science and technology company, in December 2023. This software accelerates drug development and enhances the success rate of novel medications and therapies by integrating computer-aided drug design, machine learning, and generative AI. Addison provides recommendations on optimal methods for synthesizing medications, bridging the gap between virtual molecule design and practical manufacturability. By extracting hidden insights from extensive datasets, the platform increases the likelihood of patients benefiting from innovative treatments.

Key players in the drugs of abuse (DOA) testing market are actively introducing new products, including advanced drug testing, to stay ahead in the market competition. Drug testing involves analyzing biological specimens, such as urine, to identify specific drugs or their metabolites. In December 2022, Omega Laboratories Inc., a US-based company specializing in forensic toxicology and hair testing services, launched urine drugs of abuse testing services. These services are known for their ease of use, rapid effects, and affordability. The laboratory provides accredited urine drug testing services, ensuring high quality and precision in test results. Serving over 6,000 clients worldwide, the organization employs both screening and confirmatory testing in urine drug abuse testing services to ensure the accuracy and reliability of the results.

In February 2021, Thermo Fisher Scientific Inc., a US-based company specializing in scientific research services, entered into a partnership with Mindray Medical International Limited, a China-based medical technology company. The collaboration aims to provide clinical laboratories, hospitals, and the criminal justice system with reliable and cost-effective tools for drug misuse screening. This partnership allows Thermo Fisher Scientific to address the needs of testing facilities looking to enhance or expand their testing capabilities, as well as those seeking to integrate and centralize their testing processes.

Major companies operating in the drugs of abuse (doa) testing market report are Siemens AG, F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Laboratory Corporation of America Holdings, Quest Diagnostics Inc., Zimmer Biomet Holdings Inc., bioMerieux Inc., Dragerwerk AG & Co. KGaA, Natera Inc., Aegis Sciences Corporation, NMS Labs, Clinical Reference Laboratory Inc., Cordant Health Solutions, Millennium Health, ACM Global Laboratories, Psychemedics Corporation, Alfa Scientific Designs Inc., Alere Toxicology Services, Omega Laboratories Inc., BioTek Laboratories, Premier Biotech Inc., Dominion Diagnostics LLC, Randox Toxicology Ltd., Cansford Laboratories Ltd., United States Drug Testing Laboratories Inc., Homology Medicines Inc., American Bio Medica Corporation, Confirm BioSciences, Immunalysis Corporation, Medtox Diagnostics Inc., Forensic Fluids Laboratories

North America was the largest region in the drugs of abuse (DOA) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global drugs of abuse (DOA) testing market report during the forecast period. The regions covered in the drugs of abuse (doa) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the drugs of abuse (doa) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The drugs of abuse (DOA) testing market includes revenues earned by entities by providing services such as analyzers, rapid testing devices, consumables, and laboratory services. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Drugs of Abuse (DOA) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on drugs of abuse (doa) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for drugs of abuse (doa) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The drugs of abuse (doa) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Product And Service: Analyzers; Rapid Testing Devices; Consumables; Laboratory Services
  • 2) By Sample Type: Urine; Hair; Oral Fluid; Breath
  • 3) By Application: Pain Management; Criminal Justice; Workplace Screening
  • 4) By End User: Hospitals; Diagnostic Laboratories; Forensic Laboratories; Other End Users
  • Companies Mentioned: Siemens AG; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific Inc.; Abbott Laboratories; Danaher Corporation
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Drugs of Abuse (DOA) Testing Market Characteristics

3. Drugs of Abuse (DOA) Testing Market Trends And Strategies

4. Drugs of Abuse (DOA) Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Drugs of Abuse (DOA) Testing Market Size and Growth

  • 5.1. Global Drugs of Abuse (DOA) Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Drugs of Abuse (DOA) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Drugs of Abuse (DOA) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Drugs of Abuse (DOA) Testing Market Segmentation

  • 6.1. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Analyzers
  • Rapid Testing Devices
  • Consumables
  • Laboratory Services
  • 6.2. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Sample Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Urine
  • Hair
  • Oral Fluid
  • Breath
  • 6.3. Global Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Pain Management
  • Criminal Justice
  • Workplace Screening
  • 6.4. Global Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Forensic Laboratories
  • Other End Users

7. Drugs of Abuse (DOA) Testing Market Regional And Country Analysis

  • 7.1. Global Drugs of Abuse (DOA) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Drugs of Abuse (DOA) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Drugs of Abuse (DOA) Testing Market

  • 8.1. Asia-Pacific Drugs of Abuse (DOA) Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Drugs of Abuse (DOA) Testing Market

  • 9.1. China Drugs of Abuse (DOA) Testing Market Overview
  • 9.2. China Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Drugs of Abuse (DOA) Testing Market

  • 10.1. India Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Drugs of Abuse (DOA) Testing Market

  • 11.1. Japan Drugs of Abuse (DOA) Testing Market Overview
  • 11.2. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Drugs of Abuse (DOA) Testing Market

  • 12.1. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Drugs of Abuse (DOA) Testing Market

  • 13.1. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Drugs of Abuse (DOA) Testing Market

  • 14.1. South Korea Drugs of Abuse (DOA) Testing Market Overview
  • 14.2. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Drugs of Abuse (DOA) Testing Market

  • 15.1. Western Europe Drugs of Abuse (DOA) Testing Market Overview
  • 15.2. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Drugs of Abuse (DOA) Testing Market

  • 16.1. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Drugs of Abuse (DOA) Testing Market

  • 17.1. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Drugs of Abuse (DOA) Testing Market

  • 18.1. France Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Drugs of Abuse (DOA) Testing Market

  • 19.1. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Drugs of Abuse (DOA) Testing Market

  • 20.1. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Drugs of Abuse (DOA) Testing Market

  • 21.1. Eastern Europe Drugs of Abuse (DOA) Testing Market Overview
  • 21.2. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Drugs of Abuse (DOA) Testing Market

  • 22.1. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Drugs of Abuse (DOA) Testing Market

  • 23.1. North America Drugs of Abuse (DOA) Testing Market Overview
  • 23.2. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Drugs of Abuse (DOA) Testing Market

  • 24.1. USA Drugs of Abuse (DOA) Testing Market Overview
  • 24.2. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Drugs of Abuse (DOA) Testing Market

  • 25.1. Canada Drugs of Abuse (DOA) Testing Market Overview
  • 25.2. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Drugs of Abuse (DOA) Testing Market

  • 26.1. South America Drugs of Abuse (DOA) Testing Market Overview
  • 26.2. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Drugs of Abuse (DOA) Testing Market

  • 27.1. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Drugs of Abuse (DOA) Testing Market

  • 28.1. Middle East Drugs of Abuse (DOA) Testing Market Overview
  • 28.2. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Drugs of Abuse (DOA) Testing Market

  • 29.1. Africa Drugs of Abuse (DOA) Testing Market Overview
  • 29.2. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Product And Service, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Drugs of Abuse (DOA) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Drugs of Abuse (DOA) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Drugs of Abuse (DOA) Testing Market Competitive Landscape
  • 30.2. Drugs of Abuse (DOA) Testing Market Company Profiles
    • 30.2.1. Siemens AG
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. F. Hoffmann-La Roche Ltd.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Thermo Fisher Scientific Inc.
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Abbott Laboratories
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Danaher Corporation
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Drugs of Abuse (DOA) Testing Market Other Major And Innovative Companies

  • 31.1. Laboratory Corporation of America Holdings
  • 31.2. Quest Diagnostics Inc.
  • 31.3. Zimmer Biomet Holdings Inc.
  • 31.4. bioMerieux Inc.
  • 31.5. Dragerwerk AG & Co. KGaA
  • 31.6. Natera Inc.
  • 31.7. Aegis Sciences Corporation
  • 31.8. NMS Labs
  • 31.9. Clinical Reference Laboratory Inc.
  • 31.10. Cordant Health Solutions
  • 31.11. Millennium Health
  • 31.12. ACM Global Laboratories
  • 31.13. Psychemedics Corporation
  • 31.14. Alfa Scientific Designs Inc.
  • 31.15. Alere Toxicology Services

32. Global Drugs of Abuse (DOA) Testing Market Competitive Benchmarking

33. Global Drugs of Abuse (DOA) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Drugs of Abuse (DOA) Testing Market

35. Drugs of Abuse (DOA) Testing Market Future Outlook and Potential Analysis

  • 35.1 Drugs of Abuse (DOA) Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Drugs of Abuse (DOA) Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Drugs of Abuse (DOA) Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer